Miles McBride tried not to rush his return from the knee injury that kept him out of five games this month, but the Knicks sixth man said after returning to action Monday night in Denver that it's something he has to do. I believe.
McBride hasn't played since Nov. 13 against the Bulls, but he scored 13 points in 28 minutes against the Nuggets on Monday.
“Honestly, I felt really good,” the fourth-year guard said after the game. “A big shout out to our training staff just for being there, a big shout out to the organization for just having my back and understanding everything, just being able to get back on the field with our players. , it felt great.”
The Knicks named McBride's injury patellofemoral pain syndrome in his left knee, commonly known as runner's knee.
“I think we're definitely going to continue to manage that,” McBride said. “I think we just want to take precautions more than anything and make sure everything is right. I think we're going to back off because we felt so good, but we just want to deal with it smartly.”
McBride, 24, is averaging 10.9 points per game and shooting 39.1 percent from 3-point range this season.
“Condition-wise, he's in pretty good shape for how long he's been out,'' manager Tom Thibodeau said. “He's a guy who can shoot the ball, he can get in the paint and break off the dribble, he can play off people really well. So I think once he gets defensive, that's a big plus for us. think”
NBA players who have made at least 100 3-pointers this season, shooting at least 50 percent from the field, 40 percent from deep, 60 percent from 2-point range, and 80 percent from free. Only OG Anunoby succeeded. Throw the line.
He is averaging 23.2 points, 6.1 rebounds and 1.3 steals in his past nine games heading into Wednesday's road game against the Mavericks.
Valuable players Achiuwa (hamstring) and Mitchell Robinson (ankle) remain out of the Knicks.
The Mavs are without Luka Doncic (wrist) and Dante Exum (wrist), while Klay Thompson (foot), Derek Lively II (illness) and former Nick Quentin Grimes (illness) are questionable. .
